Spots Global Cancer Trial Database for Multi-Institutional Registry for Prostate Cancer Radiosurgery
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Multi-Institutional Registry for Prostate Cancer Radiosurgery
Official Title: Multi-Institutional Registry for Prostate Cancer Radiosurgery. An IRB Approved Observational Trial
Study ID: NCT01226004
Interventions
Study Description
Brief Summary: To address pertinent questions regarding the utilization of stereotactic Body Radiotherapy (SBRT) to treat prostate cancer. The Florida Robotic Radiosurgery Association (FRRA) launched the first registry for prostate cancer patients treated with SBRT. The registry is designed to track surrogate treatment endpoints including prostate specific antigen (PSA), international prostate symptom score (IPSS),sexual health in men (SHIM), and visual analogue scale (VAS) scores, in addition to physical and survival data. Utilizing an independent vendor (Advertek, Inc.) experienced with the design and implementation of similar electronic registries, FRRA developed a data collection tool that staff members with a basic medical background can use to register and upload pertinent patient data, requiring no more than 20 to 30 minutes per patient. Participating patients will be monitored in follow-up for three years, with analysis and publication of the results semi-annually.
Detailed Description: To address pertinent questions regarding the utilization of radiosurgery (SBRT) to treat prostate cancer. The Florida Robotic Radiosurgery Association (FRRA) launched the first registry for prostate cancer patients treated with SBRT. The registry is designed to track surrogate treatment endpoints including PSA, IPSS, SHIM, QOL, Karnofsky Performance Status, VAS scores, urine and bowel health, in addition to physical and survival data. Utilizing an independent vendor (Advertek, Inc.) experienced with the design and implementation of similar electronic registries. FRRA developed a data collection tool that staff members with a basic medical background can use to register and upload pertinent patient data requiring no more than 20 to 30 minutes per patient. Participating patients will be monitored in follow-up for three years, with analysis and publication of the results semi-annually.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
CyberKnife of Birmingham, Birmingham, Alabama, United States
University of South Alabama-USA Mitchell Cancer Institute, Mobile, Alabama, United States
Phoenix CyberKnife & Radiation Oncology Center, Phoenix, Arizona, United States
California Cancer Care, Fresno, California, United States
Newport Diagnostic Center, Newport Beach, California, United States
Scripps Clinic Radiation Therapy Centers, San Diego, California, United States
Skyline Radiation Oncology, Tustin, California, United States
Penrose Cancer Center, Colorado Springs, Colorado, United States
Colorado CyberKnife, Lafayette, Colorado, United States
Anova Cancer Care, Lone Tree, Colorado, United States
Georgetown University, Washington, District of Columbia, United States
CyberKnife Center of Miami, Miami, Florida, United States
Naples Radiation Oncology, Naples, Florida, United States
Memorial Cancer Institute CyberKnife Center, Pembroke Pines, Florida, United States
CyberKnife Center of South Florida in Stuart, Stuart, Florida, United States
CyberKnife Centers of Tampa Bay, Tampa, Florida, United States
WellStar Research Insititute, Marietta, Georgia, United States
CyberKnife Center of Chicago, Elmhurst, Illinois, United States
Illinois Cyberknife, Park Ridge, Illinois, United States
Baptist Health, Lexington, Kentucky, United States
Saint Vincent Frontier Cancer Center, Billings, Montana, United States
Benefis Sletten Cancer Institute, Great Falls, Montana, United States
Montana Cancer Institute Foundation, Missoula, Montana, United States
St. Elizabeth CyberKnife Center, Lincoln, Nebraska, United States
Las Vegas CyberKnife, Henderson, Nevada, United States
Reno CyberKnife, Reno, Nevada, United States
Riverview Medical Center, Red Bank, New Jersey, United States
United Health Services, Johnson City, New York, United States
First Dayton Cancer Care, Kettering, Ohio, United States
St. John Medical Center, Tulsa, Oklahoma, United States
Oklahoma CyberKnife, Tulsa, Oklahoma, United States
Cancer Treatment Centers of America, Tulsa, Oklahoma, United States
Philadelphia CyberKnife, Havertown, Pennsylvania, United States
Sarah Cannon Cancer Center, Nashville, Tennessee, United States
Austin CyberKnife, Austin, Texas, United States
Premier Cancer Centers, Dallas, Texas, United States
The Center for Cancer and Blood Disorders, Fort Worth, Texas, United States
St. Luke's Medical Center, Houston, Texas, United States
The START Center for Cancer Care, San Antonio, Texas, United States
Cyberknife of Texas at East Texas Medical Center, Tyler, Texas, United States
Inova Fairfax Hospital, Falls Church, Virginia, United States
Spokane CyberKnife, Spokane Valley, Washington, United States
PeaceHealth Southwest Medical Center, Vancouver, Washington, United States
St. Mary's Medical Center, Huntington, West Virginia, United States
Contact Details
Name: Mark L. Perman, MD
Affiliation: South Florida Radiation Oncology, LLC.
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
